The PennZone

PHILADELPHIA, Sept. 3, 2024 ~ Carisma Therapeutics Inc. (Nasdaq: CARM) has announced that its President and Chief Executive Officer, Steven Kelly, will be participating in several upcoming conferences. The clinical-stage biopharmaceutical company is focused on developing innovative immunotherapies.

Kelly will be speaking at the Baird 2024 Global Healthcare Conference on Tuesday, September 10 at 12:50 PM ET in New York City. He will also be presenting at the H.C. Wainwright 26th Annual Global Investment Conference on Wednesday, September 11 at 1:30 PM ET in New York City.

More on The PennZone

• e4health Earns 2025-2026 Great Place To Work Certification™ for Fourth Consecutive Year
• Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
• NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
• Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
• Palmer Lake Wine Festival To Build Bridges in Small Mountain Community, Highlight Local Businesses

In addition, Kelly will be attending Chardan's 8th Annual Genetic Medicines Conference on Monday, September 30 at 4:00 PM ET in New York City and The Cell & Gene Meeting on the Mesa on Monday, October 7 at 9:30 AM MST in Phoenix, AZ.

For those unable to attend these events in person, live webcasts will be available on Carisma's Investor Events webpage. A replay of the webcasts will also be archived for a limited time following each event. Investors and stakeholders are encouraged to tune in to hear updates from Carisma's leadership team and learn more about the company's progress and future plans.

---

Show All News | Report Violation